Danone's Irini Schoeman-Giziakis discusses open innovation, nutrition in the GLP-1 era, and artificial intelligence.
The company is focused on meeting the nutritional needs of people taking GLP-1 drugs or trying to retain weight loss after coming off them.
It's early days, says the firm's open innovation manager Irini Schoeman-Giziakis.
There are active discussions in the industry as to whether to position existing products as "GLP-1 friendly" or steer patients towards them via nutrition or online shopping apps.
Danone is the maker of Activia, Alpro, Silk, and Evian.
Author's summary: Danone explores open innovation and GLP-1 era nutrition.